In a recent development, DRDO released a statement saying that its lab has developed an antibody detection-based kit DIPCOVAN, the DIPAS-VDx COVID 19 IgG Antibody Microwell ELISA for sero-surveillance.
The kit can detect spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97% & specificity of 99%, added DRDO.
It’s been developed in association with Vanguard Diagnostics Pvt Ltd, a Delhi based development & manufacturing diagnostics company, it said.
DRDO further said that it was developed indigenously by scientists, followed by extensive validation on over 1000 patient samples at various COVID hospitals in Delhi.
3 batches of product were validated during last one year. Antibody detection kit is approved by ICMR in April 2021. In May 2021, the product received the regulatory approval from the DCGI, CDSCO, Ministry of Health & Family Welfare, to manufacture for sale & distribution, ANI reported quoting DRDO.
